Back to Search
Start Over
Supplementary Figure S2 from Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure S2: The in vitro effects of taselisib, lapatinib and trastuzumab in HER2+ breast cancer cell lines.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....1a38248dc57cc8d686776b8f0e2289ee